Qiming Wang

Qiming Wang

Program: Cancer Therapeutics

qjw1@pitt.edu E1354 BSTWR
200 Lothrop Street
Pittsburgh, PA 15260

Summary

Dr. Wang's laboratory conducts basic and translational research on oncogenic protein kinases, with a focus on diacylglycerol-regulated kinases, cell cycle checkpoint kinases, and the development of targeted cancer therapies against these enzymes. Her work combines molecular, cellular, genetic, and in vivo approaches to uncover the roles of these kinases in cancer progression, particularly in prostate cancer. The lab has pioneered the development of selective PKD inhibitors with in vivo efficacy, advancing them as potential targeted therapies for cancer. Her research bridges cancer biology and drug discovery to drive new therapeutic strategies.


 

Research Interests and Keywords

  • Cancer pharmacology
  • Drug Discovery
  • protein kinases & phosphatases
  • Signal Transduction
  • structural pharmacology

View Investigators by Last Name